VIRGINAL RECURRENT GIGANTOMASTIA (BREAST HYPERTROPHY). A CASE REPORT

Area of Science:

• Oncology
• Endocrinology
• Pathology

Background:

• Virginal gigantomastia (VGM) is a rare benign breast condition with unclear etiology and challenging treatment options.
• Current treatments like conservative methods are ineffective, while mastectomy is overly traumatic, necessitating alternative approaches.

Observation:

• A patient with VGM underwent reduction mammoplasty in 2014, experiencing a relapse after 9 years.
• The relapse involved extensive fibrosis, hamartomas, and fibroadenomas, with high estrogen and progesterone receptor expression (70%).

Findings:

• The patient underwent a second breast-conserving surgery with reduction mammoplasty.
• Post-surgery, hormone therapy with tamoxifen (10 mg/day) was initiated, with dynamic monitoring for remission.

Implications:

• Breast-conserving surgery, combined with adjuvant hormone therapy, can be an effective strategy for managing recurrent VGM.
• This approach can significantly alleviate the psychological, social, and physical burdens associated with VGM.